140 related articles for article (PubMed ID: 34911380)
1. Complications Associated With Totally Implanted Venous Access Devices in the Arm Versus the Chest: A Short-Term Retrospective Study.
Pike S; Tan K; Burbridge B
Can Assoc Radiol J; 2022 Aug; 73(3):581-588. PubMed ID: 34911380
[TBL] [Abstract][Full Text] [Related]
2. Risk of thrombosis and infections of central venous catheters and totally implanted access ports in patients treated for cancer.
Beckers MM; Ruven HJ; Seldenrijk CA; Prins MH; Biesma DH
Thromb Res; 2010 Apr; 125(4):318-21. PubMed ID: 19640573
[TBL] [Abstract][Full Text] [Related]
3. Complication Rates Observed in Silicone and Polyurethane Catheters of Totally Implanted Central Venous Access Devices Implanted in the Upper Arm.
Busch JD; Vens M; Mahler C; Herrmann J; Adam G; Ittrich H
J Vasc Interv Radiol; 2017 Aug; 28(8):1177-1183. PubMed ID: 28549710
[TBL] [Abstract][Full Text] [Related]
4. Experience with 100 consecutive central venous access arm ports placed by interventional radiologists.
Hills JR; Cardella JF; Cardella K; Waybill PN
J Vasc Interv Radiol; 1997; 8(6):983-9. PubMed ID: 9399467
[TBL] [Abstract][Full Text] [Related]
5. A Comparison Between Upper Arm and Chest for Optimal Site of Totally Implanted Venous Access Ports in Patients with Female Breast Cancer.
Yang SS; Ahn MS
Ann Vasc Surg; 2018 Jul; 50():128-134. PubMed ID: 29481918
[TBL] [Abstract][Full Text] [Related]
6. Implanting totally implantable venous access ports in the upper arm is feasible and safe for patients with early breast cancer.
Xu H; Chen R; Jiang C; You S; Zhu Q; Li Y; Li S; Zha X; Wang J
J Vasc Access; 2020 Sep; 21(5):609-614. PubMed ID: 31841061
[TBL] [Abstract][Full Text] [Related]
7. Randomized Clinical Trial Evaluating Complications and Complication-Related Removal of Arm-Situated Power-Injectable and Non-Power-Injectable Totally Implanted Venous Access Devices among Cancer Patients.
Burbridge B; Plewes C; Stoneham G; Szkup P; Otani R; Babyn P; Bryce R
J Vasc Interv Radiol; 2018 May; 29(5):648-656.e3. PubMed ID: 29499999
[TBL] [Abstract][Full Text] [Related]
8. A retrospective analysis on the utility and complications of upper arm ports in 433 cases at a single institute.
Mori Y; Nagayama S; Kawamura J; Hasegawa S; Tanaka E; Okabe H; Takeuchi M; Sonobe M; Matsumoto S; Kanai M; Muto M; Chiba T; Sakai Y
Int J Clin Oncol; 2016 Jun; 21(3):474-82. PubMed ID: 26507141
[TBL] [Abstract][Full Text] [Related]
9. Follow-up of radiologically totally implanted central venous access ports of the upper arm: long-term complications in 127,750 catheter-days.
Busch JD; Herrmann J; Heller F; Derlin T; Koops A; Adam G; Habermann CR
AJR Am J Roentgenol; 2012 Aug; 199(2):447-52. PubMed ID: 22826411
[TBL] [Abstract][Full Text] [Related]
10. Totally implantable venous access devices in children with cystic fibrosis: incidence and type of complications.
Deerojanawong J; Sawyer SM; Fink AM; Stokes KB; Robertson CF
Thorax; 1998 Apr; 53(4):285-9. PubMed ID: 9741372
[TBL] [Abstract][Full Text] [Related]
11. Patient preferences and willingness to pay for central venous access devices in breast cancer: A multicenter discrete choice experiment.
Liu S; Xiang Y; Gu Y; Chen N; Fu P; Wei Y; Zhao P; Li Y; Du C; Mu W; Xia Z; Chen Y
Int J Nurs Stud; 2024 Apr; 152():104695. PubMed ID: 38301304
[TBL] [Abstract][Full Text] [Related]
12. Polyurethane versus silicone catheters for central venous port devices implanted at the forearm.
Wildgruber M; Lueg C; Borgmeyer S; Karimov I; Braun U; Kiechle M; Meier R; Koehler M; Ettl J; Berger H
Eur J Cancer; 2016 May; 59():113-124. PubMed ID: 27023050
[TBL] [Abstract][Full Text] [Related]
13. Chest-to-arm tunneling: A novel technique for medium/long term venous access devices.
Annetta MG; Ostroff M; Marche B; Emoli A; Musarò A; Celentano D; Taraschi C; Dolcetti L; Greca A; Scoppettuolo G; Pittiruti M
J Vasc Access; 2023 Jan; 24(1):92-98. PubMed ID: 34148390
[TBL] [Abstract][Full Text] [Related]
14. Peripheral venous access ports: outcomes analysis in 109 patients.
Bodner LJ; Nosher JL; Patel KM; Siegel RL; Biswal R; Gribbin CE; Tokarz R
Cardiovasc Intervent Radiol; 2000; 23(3):187-93. PubMed ID: 10821892
[TBL] [Abstract][Full Text] [Related]
15. Clinical impact of peripherally inserted central catheters vs implanted port catheters in patients with cancer: an open-label, randomised, two-centre trial.
Taxbro K; Hammarskjöld F; Thelin B; Lewin F; Hagman H; Hanberger H; Berg S
Br J Anaesth; 2019 Jun; 122(6):734-741. PubMed ID: 31005243
[TBL] [Abstract][Full Text] [Related]
16. A novel incision technique of a totally implanted venous access port in the upper arm for patients with breast cancer.
Song X; Chen S; Dai Y; Sun Y; Lin X; He J; Xu R
World J Surg Oncol; 2023 May; 21(1):162. PubMed ID: 37237419
[TBL] [Abstract][Full Text] [Related]
17. A rare complication of implanted central-venous access devices: catheter fracture and embolization.
Debets JM; Wils JA; Schlangen JT
Support Care Cancer; 1995 Nov; 3(6):432-4. PubMed ID: 8564351
[TBL] [Abstract][Full Text] [Related]
18. Use of infusion ports in patients with sickle cell disease: Indications and complications.
Ilonze C; Anderson M; Stubblefield A; Journeycake J; Sinha AA
Pediatr Blood Cancer; 2022 Feb; 69(2):e29445. PubMed ID: 34786823
[TBL] [Abstract][Full Text] [Related]
19. Comparison of peripherally inserted central catheters and totally implanted venous access devices as chemotherapy delivery routes in oncology patients: A retrospective cohort study.
Yun WS; Yang SS
Sci Prog; 2021; 104(2):368504211011871. PubMed ID: 33950754
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of upper extremity implanted venous access devices in oncology patients.
Lyon RD; Griggs KA; Johnson AM; Olsen JR
J Vasc Interv Radiol; 1999 Apr; 10(4):463-71. PubMed ID: 10229476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
